Latest News of DLB
Dolby Laboratories (NYSE:DLB) investors are sitting on a loss of 23% if they invested three years ago
By Yahoo! Finance |
2 months ago
To justify individual stock selection, aim to outperform market index funds. Dolby Laboratories (NYSE:DLB) shareholders have faced a 26% decline in the last 3 years, with EPS falling 8.4% annually....
Does The Market Have A Low Tolerance For Dolby Laboratories, Inc.'s (NYSE:DLB) Mixed Fundamentals?
By Yahoo! Finance |
4 months ago
Dolby Laboratories' stock has declined, but it's important to consider its ROE. ROE of 7.9% indicates its profit generation efficiency. The company's low ROE compared to industry average and declining...
Owning 39% shares,institutional owners seem interested in Ponce Financial Group, Inc. (NASDAQ:PDLB),
By Yahoo! Finance |
4 months ago
Analyzing ownership research and past performance data can reveal stock opportunities. Institutional investors hold 39% of Ponce Financial Group, indicating potential upside. Hedge funds and insiders ...
-
Roche's Columvi shows to offer extended survival in Phase III DLBCL trial
By Yahoo! Finance | 4 months agoRoche's Phase III STARGLO trial showed Columvi with GemOx extended survival in relapsed/refractory DLBCL patients. Results indicated a 41% reduction in mortality risk compared to R-GemOx, meeting prim...
-
EHA 2024: Roche's Columvi competes in BiTE battle with positive results in DLBCL
By Yahoo! Finance | 4 months agoRoche's Columvi (glofitamab) showed positive results in the STARGLO trial for relapsed/refractory DLBCL patients. The trial demonstrated improved survival outcomes with potential to compete with other...